Using a CRISPR-based screening approach with confirmatory KD, pharmacologic and amino acid deprivation experiments we find that MLL-translocated AML cells exhibit increased sensitivity to mTORC1 inhibition in the presence of pharmacologic inhibition of LSD1. This evidence concerns the gene KMT2A and acute myeloid leukemia.